Abstract
Purpose of review
It is now 50 years since the concept of spondyloarthritis was introduced by Moll, Wright and co-authors from Leeds, UK. This review will review the original concept and mark significant milestones over the last 50 years while looking ahead to developments in the future.
Recent findings
While the diseases included under this rubric in the original description may have changed the core conditions remain and are still characterized by axial inflammation as a common feature. Imaging, animal models, genetics and immunology have contributed to our knowledge of the pathogenesis and classification of these diseases and have led to the development of more effective treatments.
Summary
Future developments, facilitated by large research consortia, will help build on our current knowledge and will help clarify disease heterogeneity and provide insights into new therapeutic pathways.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference39 articles.
1. Associations between ankylosing spondylitis, psoriatic arthritis, Reiters’ disease, the intestinal arthropathies, and Behcet's syndrome;Moll;Medicine (Baltimore),1974
2. Ankylosing spondylitis and HL-A27;Brewerton;Lancet,1973
3. High association of an HL-A antigen, W27 with ankylosing spondylitis;Schlosstein;N Engl J Med,1973
4. The pathology of joint lesions in patients with psoriasis and arthritis;Bauer;Tran Assoc Am Phys,1941
5. Psoriatic arthritis: Mary Stults Sherman, a forgotten figure in its history;Espinoza;Clin Rheumatol,2014